28
FEB
Reports
Q4, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
40.72
-0.43
(-1.05%)
EPS
$-0.713333
Estimated Sales
$915.75K
Market Cap
$2.06B
Trade
Mentioned
CLDX
-0.76 (-1.84%)
S
40.56
B
40.82
@MarketUpdates
United Kingdom10 months ago
28
FEB
Reports
Q4, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
40.72
-0.43
(-1.05%)
EPS
$-0.713333
Estimated Sales
$915.75K
Market Cap
$2.06B
Trade
1 Mentioned
CLDX
Celldex Therapeutics Inc